News FDA Approves Faricimab for nAMD and Diabetic Macular Edema by Medscape • 2022/01/29 • 0 Comments The US Food and Drug Administration has approved faricimab, a drug with the potential to reduce the number of injections needed to treat diabetic macular edema and neovascular age-related macular degeneration. FDA Approvals Full Story →